Collaborate on the development and administration of harm reduction initiatives in the NYC shelter system including planning, developing, implementing, coordinating, and evaluating program activities.
Develop harm reduction program goals, objectives, and strategies in alignment with organizational mission, principles of harm reduction and public health best practices.
Supervise and coordinate a team of harm reduction specialists to deliver direct services to clients across the NYC shelter system.
Facilitate team meetings and training sessions to enhance staff knowledge and skills in harm reduction strategies and client engagement.
Foster a collaborative team environment, encouraging open communication and professional development among team members.
Monitor and evaluate service delivery outcomes to maintain high standards of care and client satisfaction.
Build relationships and collaborate with harm reduction community organizations, healthcare providers, shelter directors, and other stakeholders to build capacity and expand access to harm reduction services in shelters.
Support development of program guides, tools, protocols, and other program materials.
Develop data management and evaluation systems, and utilize data to support program monitoring, reporting, evaluation, and improvement.
Project Manager
Mount Sinai Medical Center
New York, NY
02.2014 - 04.2022
Responsible for the overall coordination and management of multiple clinical research projects from start-up through close-out activities, ensuring adherence to timelines, budgets, regulatory requirements, protocols and standard operating procedures (SOPs).
Oversaw development and implementation of study protocols, informed consent documents, case report forms (CRFs) and standard operating procedures (SOPs).
Prepared and maintained regulatory documents and submissions, such as IRB applications, modifications, and progress reports.
Developed and oversaw recruitment strategies for multiple high-yield studies.
Supervised and monitored data management operations for multiple study databases to ensure adherence to IRB approved protocols, Good Clinical Practices, and HIPAA.
Collaborated with interdisciplinary teams, including investigators, sponsors, and healthcare professionals, to support seamless study implementation and execution.
Assisted in the development of new research grant/contract proposals, including developing budgets and budget narratives.
Contributed to study progress reports, presentations, and publications.
Recruited, trained, and provided ongoing supervision of clinical research staff personnel.
Clinical Research Study Coordinator
Comprehensive Arrhythmia Research and Management (CARMA) Center
Salt Lake City, UT
02.2011 - 02.2014
Primary study coordinator for 4 FDA-regulated studies, encompassing both PI-initiated and industry-sponsored studies.
Screened, recruited, and consented participants for clinical trials, and maintained their study records.
Coordinated studies that required pharmacy interaction, as well as interaction with multiple clinical areas of the hospital and research partners.
Developed and maintained study SOPs.
Collected sensitive participant data according to IRB-approved protocols, Good Clinical Practices, and HIPAA.
Created, maintained, and audited regulatory binders, study databases, and participant study files.
Collaborated with the PI to prepare IRB documents and any other regulatory submissions.
Compiled data for DSMB review.
Documented and reported adverse events to the IRB and sponsor.
Coordinated studies from start-up to closeout.
Led 2 studies through external audit preparation, audit proceedings, and follow-up.
Senior Clinical Research Coordinator
Mount Sinai Medical Center
New York, NY
Collaborated closely with PIs to develop and prepare study protocols, consent documents, and all other regulatory IRB submissions.
Participated in the development of study-related documents, such as protocols, informed consent documents, and case report forms (CRFs).
Managed and delegated participant recruitment, screening, and enrollment for all multiple studies.
Collected sensitive participant data according to IRB-approved protocols, Good Clinical Practices, and HIPAA.
Prepared for and managed site monitoring visits for industry-sponsored studies.
Developed and maintained ongoing study databases using electronic data capture systems, including REDcap, with data on over 1,200 subjects.
Established and managed an extensive biobank of frozen DNA, serum, and plasma specimens for research.
Trained and mentored a new clinical research staff member.
Clinical Research Coordinator
Mount Sinai Medical Center
New York, NY
Supported PIs to develop and prepare study protocol, consent documents, and all other regulatory IRB submissions.
Screened, recruited, and consented participants for clinical trials, and maintained their study records.
Gathered sensitive participant data according to IRB approved protocols, Good Clinical Practices (GCP), and HIPAA regulations.
Created, maintained, and audited regulatory binders, study databases, and participant study files.
Participated in the development of study-related documents, such as protocols, informed consent documents, and case report forms (CRFs).
Supported the implementation of REDcap efficient data collection, ensuring quality clinical data management.
Processed and cataloged over 500 DNA, serum, and plasma specimens for bio-banking, ensuring accurate labeling and storage protocols to maintain sample integrity for ongoing clinical studies.
Education
Master’s in Public Health - Disease Prevention and Health Promotion
Icahn School of Medicine at Mount Sinai
New York, NY
06.2021
Bachelor of Arts - Public Health
Sarah Lawrence College
Bronxville, NY
05.2009
Skills
Project management
Program evaluation
Stakeholder engagement and relationship building
Data management
Regulatory Compliance
Microsoft Office Suite
Team leadership and collaboration
Communication
Adaptability
Problem-solving
Time management
Organizational skills
Publications
Significant number of undetected cardiac arrhythmias in the community: Lessons learned from cardiac screenings, Windfelder, J., APRN; Aronson, A.; Kanamu, L., APRN, et al., 33rd Annual Heart Rhythm Society Conference, 05/09/2012, Boston, MA
Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis, Amin, S., Mhango, G., Lin, J., Aronson, A., Wisnivesky, J., Boffetta, P., & Lucas, A. L., The American journal of gastroenterology, 111, 9, 1350–1357, 09/01/2016, 10.1038/ajg.2016.288
No Increase in Prevalence of Pancreatic Cysts in BRCA1 or BRCA2 Mutation Carriers with Breast Cancer, Welinsky S., Becker A, Aronson A, Hernandez Y, Soper E, Lucas AL., Annual Digestive Disease Week, 05/21/2016, San Diego, CA
Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors, Martin JA, Warner RRP, Aronson A, Wisnivesky JP, Kim MK., Pancreas, 46, 9, 1214-1218, 10/01/2017, 10.1097/MPA.0000000000000921, 28902794, PMC5658015
Impact of Mesenteric Mass in Patients With Midgut Neuroendocrine Tumors, Malik P, Pinto C, Naparst MS, Ward SC, Aronson A, Aalberg JJ, Divino CM, Kim MK., Pancreas, 48, 5, 682-685, 05/01/2019, 10.1097/mpa.0000000000001309, 31091215
Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States, Lee M, Harris C, Baeg Aronson A, Wisnivesky JP, Kim MK., Clinical Gastroenterology and Hepatology, 12/20/2018, 10.1016/j.cgh.2018.12.017
Elevated hemoglobin A1c is associated with the presence of pancreatic cysts in a high-risk pancreatic surveillance program, Bar-Mashiah, A., Aronson, A., Naparst, M., Dimaio, C., Lucas, A., BMC Gastroenterology, 05/27/2020, 10.1186/s12876-020-01308-w
Psychological distress in the face of a pandemic: An observational study characterizing the impact of COVID-19 on immigrant outpatient mental health, Serafini, R., Powell, S., Frere, J., Saali, A., Krystal, H., Kumar, V., Yashaswini, C., Hernandez, J., Moody, K., Aronson, A., Meah, Y., Katz, C., Psychiatry Research, 295, 2021, 10.1016/j.psychres.2020.113595
Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population, Brewer MJ, Doucette JT, Bar-Mashiah A, Glickman J, Kessel E, Aronson A, Lucas A., Clinical Gastroenterology and Hepatology, 08/03/2021, 10.1016/j.cgh.2021.07.046
Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis, Zylberberg HM, Rustgi SD, Yang A, Aronson A, Kessel E, Amin S, Lucas AL., Gut and Liver, 10.5009/gnl20297
Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy, Fulop DJ, Zylberberg HM, Wu YL, Aronson A, et al., JAMA Netw Open, 6, 3, 2023, 10.1001/jamanetworkopen.2023.4254
Timeline
Harm Reduction Program Manager
NYC Department of Homeless Services
04.2022 - Current
Project Manager
Mount Sinai Medical Center
02.2014 - 04.2022
Clinical Research Study Coordinator
Comprehensive Arrhythmia Research and Management (CARMA) Center
02.2011 - 02.2014
Senior Clinical Research Coordinator
Mount Sinai Medical Center
Clinical Research Coordinator
Mount Sinai Medical Center
Master’s in Public Health - Disease Prevention and Health Promotion